Showing results (1791-1800 of 2,335) with videos related to
Sort By:
Pageof 234
Journal of Human Evolution|March 19, 2023
Early Upper Paleolithic cultural variability in the Southern Levant: New evidence from Nahal Rahaf 2 Rockshelter, Judean Desert, IsraelMaayan Shemer, Elisabetta Boaretto, Noam Greenbaum, et al.Nature Communications|October 20, 2019
Rapid multiple-quantum three-dimensional fluorescence spectroscopy disentangles quantum pathwaysStefan Mueller, Julian Lüttig, Pavel Malý, et al.The Journal of Organic Chemistry|March 15, 2023
Dirhodium C-H Functionalization of Hole-Transport MaterialsFarzaneh Saeedifard, Yasir Naeem, Yannick T Boni, et al.Neurology|February 6, 2015
Differential effects of severe vs mild GBA mutations on Parkinson diseaseZiv Gan-Or, Idan Amshalom, Laura L Kilarski, et al.Environmental Research|December 25, 2022
Elimination of PBB-153; findings from a cohort of Michigan adultsRobert B Hood, Metrecia L Terrell, Alicia K Smith, et al.Journal of the American Chemical Society|April 13, 2016
Preparing (Multi)Fluoroarenes as Building Blocks for Synthesis: Nickel-Catalyzed Borylation of Polyfluoroarenes via C-F Bond CleavageJing Zhou, Maximilian W Kuntze-Fechner, Rüdiger Bertermann, et al.The American Journal of Psychiatry|March 22, 2017
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive DyskinesiaRobert A Hauser, Stewart A Factor, Stephen R Marder, et al.Lancet (London, England)|February 11, 2017
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trialGyörgy Németh, István Laszlovszky, Pál Czobor, et al.Schizophrenia Research|July 31, 2007
Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trialJonathan K Wynn, Michael F Green, Joyce Sprock, et al.Annals of Neurology|June 29, 2005
A 10-item smell identification scale related to risk for Alzheimer's diseaseMatthias H Tabert, Xinhua Liu, Richard L Doty, et al.Pageof 234